Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23455,85,1.11 [0.92-1.34],0.2601479408503889
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23950,126,1.00 [0.86-1.16],0.95213748361472
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23742,872,1.04 [0.98-1.10],0.1955281304455977
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Candidiasis,23974,255,1.03 [0.92-1.14],0.6077638240875051
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23291,2374,1.03 [1.00-1.07],0.084335924687186
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23515,1797,1.02 [0.98-1.06],0.3537154086419956
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23802,863,1.02 [0.96-1.08],0.4599824835452887
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23908,37,0.86 [0.65-1.13],0.2703373023348574
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22874,556,1.03 [0.96-1.11],0.4076294350277256
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,22102,528,1.03 [0.96-1.11],0.4338386685459915
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,22317,146,1.01 [0.88-1.16],0.9048062313446958
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17806,1046,1.05 [0.99-1.10],0.088951847496533
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,22122,249,1.03 [0.92-1.14],0.6527050206496132
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23942,1003,1.02 [0.96-1.07],0.5717781392484436
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Mycoses,24031,312,1.01 [0.92-1.11],0.8741717751208082
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23399,529,1.03 [0.96-1.11],0.4342562701766669
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23980,610,1.04 [0.97-1.11],0.2887440737358759
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,23067,128,0.99 [0.85-1.15],0.8875320339545405
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,24074,26,1.09 [0.78-1.53],0.614315293307266
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23907,537,1.02 [0.95-1.10],0.6355846453274735
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23934,63,1.04 [0.84-1.29],0.739555021023361
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23986,151,1.11 [0.96-1.27],0.1532678244023452
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23971,136,1.11 [0.96-1.29],0.1569456986972333
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,23168,298,1.10 [0.99-1.21],0.063511645871016
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,23075,205,1.03 [0.92-1.16],0.6062700633445179
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,23003,64,0.97 [0.78-1.19],0.7547653350647119
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,24049,46,0.96 [0.75-1.23],0.7674518909212864
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,24019,115,0.92 [0.79-1.08],0.2968857699323345
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Viral warts,23943,39,0.83 [0.64-1.09],0.1785947911064226
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23949,45,0.96 [0.75-1.24],0.7651521161173724
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign lipomatous neoplasm,23815,276,1.17 [1.05-1.30],0.0030622182703483
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23996,64,1.15 [0.93-1.43],0.1998797852148405
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23972,68,1.31 [1.06-1.62],0.0123134778961986
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10735,35,1.22 [0.91-1.64],0.1871074082426416
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23894,1014,1.01 [0.96-1.06],0.7727275584494129
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm of meninges,24062,41,1.01 [0.77-1.31],0.9619790670526418
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24044,44,0.83 [0.65-1.07],0.1492657413885627
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,24052,79,1.11 [0.91-1.35],0.290508146412497
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm of ovary,13282,84,0.99 [0.82-1.19],0.873423930137267
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm: Ascending colon,24066,237,0.95 [0.85-1.06],0.3943817061459681
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm: Caecum,24063,178,1.01 [0.89-1.15],0.8518467605227851
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24007,47,1.06 [0.83-1.36],0.639425253205335
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm: Descending colon,24069,153,0.90 [0.79-1.04],0.146429256163914
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm: Rectum,24035,249,0.95 [0.85-1.06],0.3622711501185204
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,24003,479,1.01 [0.94-1.09],0.7560494652315771
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm: Transverse colon,24066,266,0.97 [0.87-1.08],0.5569229914653913
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Carcinoma in situ of breast,11384,76,0.80 [0.66-0.97],0.0233186842392548
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",11422,85,0.89 [0.74-1.06],0.1939883904805163
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",20765,30,0.90 [0.66-1.22],0.4851009326443102
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",20770,35,0.85 [0.64-1.12],0.2425296677471491
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",24036,94,0.95 [0.80-1.13],0.5895685871576799
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Haemangioma, any site",24036,92,0.95 [0.80-1.14],0.5920891720709519
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Leiomyoma of uterus,12715,355,0.97 [0.88-1.06],0.4883090583501566
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Lung cancer and mesothelioma,17830,160,1.07 [0.94-1.23],0.3029124157116783
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Lymphoid leukaemia,20762,27,0.96 [0.69-1.33],0.7925226718364161
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",20861,126,1.01 [0.87-1.18],0.849653038317915
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",20813,78,1.03 [0.85-1.25],0.7670146324398117
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",11469,67,0.93 [0.76-1.14],0.5024458185246037
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",20778,43,0.74 [0.57-0.94],0.0152348903300109
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",20789,54,1.07 [0.85-1.35],0.5752621749679532
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",20800,65,1.05 [0.85-1.29],0.6691002047971215
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",11450,48,1.16 [0.90-1.49],0.2396826524980337
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",20786,51,1.10 [0.86-1.40],0.4406294657697592
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9673,340,1.06 [0.96-1.16],0.2274521204026783
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",20816,81,1.01 [0.84-1.22],0.918184372562063
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",20783,48,1.10 [0.86-1.41],0.4575637622610804
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,20790,55,0.91 [0.73-1.14],0.4252989541142394
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Melanocytic naevi,23868,188,1.01 [0.89-1.14],0.9357403223347798
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Melanocytic naevi of trunk,24032,86,0.97 [0.80-1.16],0.7122326121568143
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Melanoma in situ,20746,40,1.28 [0.97-1.69],0.0841713068979809
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",20791,56,0.95 [0.76-1.19],0.6670080635892498
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",20839,104,0.96 [0.82-1.14],0.6572716195856726
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",20842,107,1.08 [0.91-1.27],0.3748861682048735
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",20794,59,0.96 [0.77-1.20],0.7247885291441398
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Other benign neoplasms of skin,23914,129,1.05 [0.90-1.22],0.541424054490816
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",21298,563,1.01 [0.94-1.09],0.7078761060989112
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",21327,592,1.01 [0.94-1.09],0.7390331441164971
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23829,256,1.01 [0.91-1.13],0.8334556734084169
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22840,41,1.17 [0.89-1.53],0.264331469526485
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23638,65,1.02 [0.83-1.26],0.8507915081155903
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23373,1937,1.04 [1.00-1.08],0.0312536236600488
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,23051,19,0.97 [0.66-1.43],0.865900413227826
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23762,29,1.05 [0.77-1.44],0.755569216871057
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23683,884,1.06 [1.00-1.12],0.0583513173678994
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23683,884,1.06 [1.00-1.12],0.0583513173678994
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22848,49,0.96 [0.76-1.23],0.7554027688779393
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23827,795,1.07 [1.01-1.14],0.0273639619877768
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23827,94,0.96 [0.81-1.14],0.6403288414433463
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23618,45,0.93 [0.72-1.20],0.579784456381069
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23611,38,1.20 [0.90-1.59],0.2093539680227163
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23906,173,0.88 [0.78-1.00],0.0542339449994269
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,24004,60,1.18 [0.95-1.48],0.1373371333157649
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23882,149,0.82 [0.72-0.94],0.0042706830566866
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,23096,64,0.93 [0.76-1.15],0.530442748044216
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,20659,177,1.02 [0.89-1.15],0.8189393285863935
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22377,106,1.07 [0.90-1.26],0.4562499832086145
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22398,127,1.07 [0.92-1.25],0.3692220861309588
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,20515,33,1.37 [1.01-1.87],0.0436971375497045
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22336,64,0.91 [0.74-1.13],0.3959029237254242
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,22014,124,0.95 [0.82-1.11],0.5476002374993693
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23945,144,1.02 [0.88-1.17],0.8166028791727862
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23848,47,0.79 [0.62-1.01],0.0594183983210008
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23833,32,1.23 [0.91-1.68],0.1794787733316239
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23718,1446,1.02 [0.97-1.07],0.4197685389799401
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21545,1405,1.02 [0.97-1.06],0.4945154072499576
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",20519,37,1.07 [0.81-1.42],0.6255566341321099
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22635,52,0.92 [0.73-1.16],0.4721147391837625
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,20643,161,1.20 [1.04-1.37],0.009789664712519
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,20537,55,1.10 [0.88-1.39],0.4009939494484783
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22566,2084,1.09 [1.05-1.14],3.663654318651533e-06
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,20587,105,1.00 [0.85-1.18],0.969260337506397
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,20824,342,1.09 [0.99-1.20],0.0679096925417816
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23988,228,1.17 [1.04-1.31],0.0075370698066951
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23851,91,1.30 [1.08-1.56],0.0054362601309855
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,20571,89,1.04 [0.86-1.24],0.7030201426840303
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",20517,35,0.98 [0.74-1.31],0.9123019119954014
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23700,1117,1.09 [1.04-1.15],0.00082894905858
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,20595,113,1.03 [0.88-1.21],0.6934135187691963
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,20616,134,0.95 [0.82-1.10],0.5056234156274224
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20820,338,1.08 [0.99-1.19],0.0911649137801779
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,20537,55,1.09 [0.86-1.37],0.4812282381232378
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23846,86,1.30 [1.07-1.57],0.0067932569290162
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,20748,266,1.03 [0.93-1.15],0.5211489738233359
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,20751,269,1.09 [0.98-1.21],0.1084600193137767
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21943,53,1.04 [0.83-1.32],0.7223173263003131
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23465,2983,1.07 [1.04-1.11],1.5421538208109953e-05
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22610,27,0.94 [0.68-1.30],0.7102877109664887
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22635,52,1.06 [0.84-1.34],0.638308906310189
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23913,1705,0.99 [0.95-1.03],0.6993035271340242
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23915,1701,0.99 [0.95-1.03],0.66385158580864
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22615,32,1.39 [1.02-1.90],0.0356470739902318
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23796,1087,1.04 [0.99-1.09],0.1520827158512487
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21268,786,1.05 [0.99-1.12],0.0971044204308267
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,24065,112,0.90 [0.77-1.05],0.1892039821859512
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,23831,30,0.86 [0.64-1.17],0.3364473759839117
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22787,78,0.96 [0.79-1.16],0.6585989581514433
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22806,97,1.15 [0.97-1.37],0.1179026112612933
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",20593,111,1.25 [1.05-1.47],0.0095961718366162
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22499,107,1.07 [0.91-1.26],0.4294305600050444
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1502,60,0.93 [0.75-1.15],0.5139733318793716
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1596,165,1.01 [0.89-1.15],0.8628639081081744
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22429,37,1.12 [0.85-1.47],0.4208413081004363
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1474,32,0.98 [0.73-1.31],0.8807020674588073
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23716,1324,1.06 [1.01-1.11],0.0131815347572742
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23861,60,0.97 [0.78-1.21],0.8001163669537058
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,22131,241,0.99 [0.88-1.10],0.7971594139778186
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20840,358,1.06 [0.96-1.16],0.2409263010240304
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23995,152,0.89 [0.78-1.02],0.1050092664145907
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23410,47,0.94 [0.73-1.20],0.5993665410618763
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Angina pectoris,22970,695,1.01 [0.95-1.08],0.7397071327617424
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Aortic aneurysm,23456,93,1.01 [0.85-1.21],0.9017204834795274
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23391,28,1.33 [0.96-1.86],0.0908616579048512
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23458,95,0.99 [0.83-1.18],0.9164580894502582
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,17109,810,1.02 [0.96-1.08],0.5704098120881339
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,AV-block,21895,159,1.04 [0.90-1.19],0.6137834585024965
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",24045,228,0.91 [0.81-1.02],0.0983901142384432
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Cardiac arrest,16393,94,1.04 [0.87-1.24],0.6779124892406749
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21853,117,0.93 [0.80-1.09],0.3930959337252746
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",21809,73,0.93 [0.76-1.14],0.4857124654675315
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,24076,15,0.71 [0.46-1.08],0.11234823620672
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Conduction disorders,22206,470,1.01 [0.93-1.09],0.8650304452140808
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23434,1168,1.07 [1.01-1.12],0.0117769217817897
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22362,5292,1.04 [1.01-1.06],0.0018350753280753
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,DVT of lower extremities,23073,160,0.90 [0.79-1.03],0.1274411216558674
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Endocarditis,21777,41,0.77 [0.60-1.00],0.0472847146823513
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23968,456,1.07 [0.98-1.15],0.1197520225831485
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Hypertension,22854,4304,1.05 [1.02-1.08],0.0003221899962331
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Hypertension, essential",22863,4313,1.05 [1.02-1.08],0.0003886881567347
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23919,50,0.77 [0.61-0.96],0.0236433476070237
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18631,81,0.90 [0.75-1.09],0.2779404293922666
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18591,41,0.85 [0.65-1.10],0.2108270923608731
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Hypotension,23986,600,0.97 [0.91-1.04],0.42556166908252
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23614,58,1.15 [0.92-1.44],0.2276260847675437
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23580,1305,1.05 [1.00-1.10],0.0340024070981789
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23881,274,1.02 [0.92-1.14],0.6401111603410647
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Left bundle-branch block,21919,183,1.06 [0.94-1.20],0.3545321353577111
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23852,525,1.04 [0.96-1.12],0.3395214756645373
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22704,429,1.04 [0.96-1.13],0.3119467543561178
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24026,106,0.95 [0.81-1.12],0.5628348108855723
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",24061,183,1.07 [0.94-1.21],0.300808191633224
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Oesophageal varices,22944,31,0.67 [0.50-0.89],0.0065608905254045
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other aneurysm,23404,41,0.88 [0.68-1.15],0.3514198073871801
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other arrhythmias,21960,224,1.02 [0.91-1.14],0.7884324661950206
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23422,59,1.17 [0.94-1.47],0.1630750484411951
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23489,126,0.93 [0.80-1.08],0.3598591450515919
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,21849,113,0.90 [0.77-1.06],0.1969867415863618
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other disorders of veins,22976,63,0.86 [0.70-1.07],0.1738004044352886
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22958,45,1.12 [0.87-1.45],0.3771104494177771
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23394,33,0.92 [0.68-1.23],0.5523796370889523
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22995,82,0.92 [0.76-1.11],0.3690719143625821
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,22253,517,1.02 [0.95-1.10],0.5890766360022731
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23428,42,0.78 [0.60-1.00],0.0483950113091063
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23674,311,1.04 [0.94-1.14],0.4750297114855222
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23681,139,0.97 [0.84-1.12],0.6869879187491388
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23569,208,0.97 [0.87-1.10],0.6730913791783993
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16514,215,0.96 [0.86-1.08],0.5044427039149799
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23526,185,1.02 [0.90-1.16],0.7281746253217914
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),23130,217,0.97 [0.87-1.09],0.6379235625026392
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23834,292,1.03 [0.94-1.14],0.5141814620133758
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,24038,277,1.06 [0.96-1.18],0.2633752235682934
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Right bundle-branch block,21887,151,0.93 [0.81-1.07],0.296096437217814
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23678,136,0.98 [0.85-1.13],0.7580006596078879
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23465,104,0.99 [0.84-1.17],0.9468837518089936
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23876,320,1.04 [0.94-1.14],0.4794061285562579
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23853,353,1.01 [0.92-1.10],0.8514652499317316
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23591,49,0.94 [0.74-1.19],0.5911792605725459
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23412,50,0.94 [0.74-1.19],0.5985052216722662
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23722,115,1.06 [0.90-1.25],0.4643725622688871
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23480,153,1.04 [0.91-1.20],0.5318909787231467
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Varicose veins,23178,265,0.94 [0.84-1.04],0.2087841409656275
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23373,44,1.02 [0.79-1.33],0.8572221556899076
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23922,455,1.01 [0.93-1.09],0.8920047808698126
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23939,332,0.99 [0.91-1.09],0.8981566274672426
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21429,1245,1.04 [0.99-1.09],0.1287479675651249
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,Any mental disorder,23417,3233,1.01 [0.98-1.05],0.3454961345675279
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23886,387,1.01 [0.93-1.10],0.7673402773381702
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21659,1475,1.01 [0.96-1.05],0.722949819350684
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20258,74,1.04 [0.85-1.27],0.6821327806865164
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,Smoking dependency,23595,1343,1.00 [0.96-1.05],0.8630318508591588
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21736,1552,1.00 [0.96-1.05],0.8806850685948413
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,Vascular dementia,23976,18,0.86 [0.58-1.28],0.4614022543195127
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Alzheimer disease,24075,64,0.84 [0.68-1.03],0.1005756673447301
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Bell's palsy,22606,66,0.96 [0.78-1.18],0.6725173262952231
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22963,423,1.03 [0.95-1.12],0.5254633816889756
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Cerebral cysts,23759,172,1.01 [0.89-1.16],0.8276345330121188
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,24000,199,1.00 [0.89-1.13],0.9836380208369832
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23945,21,1.01 [0.70-1.47],0.9375297992353688
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,24064,48,1.03 [0.81-1.32],0.7927157158829555
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23637,50,0.94 [0.74-1.19],0.5824495522852239
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Epilepsy,22716,229,0.95 [0.85-1.06],0.3353471503288416
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23649,1162,1.02 [0.97-1.08],0.3442189230303603
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,24047,164,1.12 [0.98-1.28],0.1109840649949171
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23636,1452,0.97 [0.92-1.01],0.1362713968885957
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Generalized epilepsy,23751,47,1.09 [0.85-1.40],0.5048510925909824
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Hemiplegia,23947,146,1.00 [0.87-1.15],0.9629445240985596
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Hydrocephalus,23630,43,1.24 [0.95-1.61],0.117524616287571
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,24055,60,1.30 [1.04-1.63],0.0217141246426384
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22608,68,0.92 [0.75-1.13],0.4281674134633655
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22609,69,1.04 [0.85-1.28],0.6968439157755799
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Memory loss,23943,67,1.00 [0.81-1.23],0.9712612289100389
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Migraine,22853,366,1.07 [0.98-1.17],0.1574362904032502
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23999,331,1.06 [0.96-1.16],0.2464915604788886
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Motor neuron disease,17481,89,1.09 [0.91-1.31],0.362404417974187
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23889,134,0.94 [0.81-1.09],0.3901175493575417
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23541,1001,1.03 [0.98-1.09],0.2652943798807896
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Neurological diseases,22803,2664,1.01 [0.98-1.05],0.4097349229010364
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23991,67,1.05 [0.86-1.30],0.618659246562155
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22884,344,1.04 [0.95-1.14],0.3677300201485198
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",24014,203,0.99 [0.88-1.12],0.9272557236912816
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,20071,282,0.94 [0.85-1.04],0.2624511169065883
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23639,52,0.92 [0.73-1.16],0.4895988030409599
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23691,104,0.95 [0.80-1.12],0.5149903887555572
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23954,71,1.10 [0.89-1.34],0.3772011555094103
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22624,84,0.95 [0.79-1.14],0.5559019230470026
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other headache syndromes,22543,56,1.05 [0.84-1.33],0.6490178596110245
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other neurological diseases,23971,384,1.03 [0.94-1.12],0.5576428909669613
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other sleep disorders,22996,509,1.04 [0.96-1.12],0.3356794279409609
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Parkinson's disease,24062,74,1.14 [0.93-1.39],0.2040481418163821
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23642,55,1.02 [0.81-1.29],0.8647835742845389
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Restless leg syndrome,24074,32,1.20 [0.88-1.63],0.2493444357956561
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Sleep apnoea,23858,443,1.04 [0.96-1.13],0.3443446873728214
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23843,32,1.13 [0.83-1.54],0.4226860435383442
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,24061,114,1.03 [0.88-1.21],0.6992606796061461
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22567,27,0.95 [0.68-1.31],0.7318133710203851
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,24075,65,0.86 [0.70-1.05],0.1450621639583671
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23964,17,0.86 [0.57-1.28],0.4514110164729209
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23654,36,0.95 [0.72-1.26],0.7237751096124025
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23757,190,1.01 [0.89-1.14],0.9221961080088018
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,24000,170,1.03 [0.90-1.17],0.6831443065460864
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23419,34,0.88 [0.66-1.18],0.3964503589709299
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23449,64,1.13 [0.91-1.40],0.2693258259658055
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23991,29,0.92 [0.67-1.26],0.5937157296443112
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23904,59,1.02 [0.82-1.28],0.8377365011241309
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1477,35,1.05 [0.79-1.39],0.7239289182439171
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1747,72,0.94 [0.78-1.15],0.5550264797183804
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23692,74,0.99 [0.82-1.21],0.9534656488892072
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23970,546,1.04 [0.96-1.12],0.3268183353387623
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23804,419,0.96 [0.88-1.04],0.2993780088049367
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23506,121,0.88 [0.76-1.02],0.0945644137611679
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23995,428,1.02 [0.94-1.11],0.614296402533272
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,24068,50,0.83 [0.65-1.05],0.1120380443017235
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23926,359,1.02 [0.93-1.11],0.6938438522991837
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",24039,194,0.97 [0.86-1.10],0.6680423544946086
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,24019,120,0.90 [0.77-1.04],0.1585368725258432
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23400,15,1.07 [0.69-1.67],0.7704759007806269
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23411,26,1.24 [0.88-1.74],0.2235423900945171
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23415,30,0.83 [0.62-1.13],0.2381647037648539
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,24033,337,1.03 [0.94-1.13],0.5827019951427942
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23777,81,0.93 [0.77-1.12],0.4488953724523692
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23588,21,1.25 [0.85-1.82],0.2583511475867083
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23907,62,1.03 [0.83-1.28],0.7863294653595849
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23979,134,0.96 [0.83-1.11],0.6070641866576013
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23714,147,1.00 [0.87-1.15],0.9772810655151724
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23969,70,0.95 [0.78-1.16],0.62107325707474
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23918,222,1.07 [0.96-1.21],0.2161898901187793
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23715,97,1.08 [0.91-1.29],0.3794652535258949
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23456,952,1.05 [0.99-1.11],0.0843399265201036
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23957,112,0.99 [0.84-1.16],0.8531683513769077
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,24054,101,1.04 [0.88-1.24],0.6151331050696541
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23619,234,0.99 [0.88-1.10],0.8200370277689625
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23880,35,0.94 [0.70-1.25],0.6566075281544779
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,24052,34,0.81 [0.61-1.08],0.1499544560731926
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23421,36,0.92 [0.69-1.22],0.5527381425447924
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23488,103,1.00 [0.84-1.18],0.9625612682191232
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23481,57,0.92 [0.74-1.15],0.4627398638498675
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23618,51,1.06 [0.84-1.35],0.6149551497093287
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23471,47,0.90 [0.71-1.15],0.404256735640905
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23741,45,1.11 [0.86-1.43],0.4303864139502229
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23776,80,0.93 [0.77-1.13],0.4710660083821334
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23460,75,1.03 [0.84-1.25],0.7895879992895662
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,23532,108,1.22 [1.03-1.44],0.0198823716309884
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23453,29,0.98 [0.71-1.35],0.908912424601398
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23229,725,1.03 [0.96-1.09],0.4069814119131874
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23428,43,0.92 [0.71-1.19],0.535026099665419
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23889,271,1.03 [0.93-1.14],0.5541263650891353
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23650,32,0.88 [0.65-1.18],0.3858070233036362
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23725,107,1.02 [0.86-1.20],0.8319334221609509
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23895,55,0.91 [0.73-1.14],0.4244659086912485
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,24035,82,1.04 [0.86-1.25],0.7000458839051874
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23964,124,0.95 [0.82-1.11],0.5339563600593632
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23891,51,0.88 [0.70-1.11],0.295029223255702
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23889,49,1.05 [0.82-1.34],0.6879495143592678
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23993,477,1.02 [0.94-1.10],0.5953702315708138
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23810,294,1.03 [0.94-1.14],0.5098074389958069
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23602,86,0.99 [0.82-1.19],0.8941647340117417
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23585,69,1.08 [0.88-1.33],0.4593650689427713
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Acute pharyngitis,23815,67,0.85 [0.69-1.04],0.1152436927234282
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23957,209,0.95 [0.84-1.06],0.3606459415918314
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23803,55,0.87 [0.70-1.09],0.2351290918450699
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,All influenza,22925,70,0.93 [0.76-1.14],0.4988448123008266
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22924,69,0.95 [0.77-1.16],0.5999495655289995
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Allergic asthma (mode),17785,115,1.06 [0.90-1.24],0.4797528949411349
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Allergic rhinitis,23955,279,1.11 [1.00-1.23],0.0489634072413604
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",19089,1550,1.03 [0.98-1.07],0.2373939884261848
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",19190,1520,1.03 [0.99-1.08],0.1831804833484457
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23823,88,1.06 [0.88-1.27],0.5346350977162473
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22907,52,1.18 [0.93-1.51],0.168641732151423
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Bronchiectasis,21390,153,1.07 [0.93-1.23],0.3265554220302873
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",21272,35,1.12 [0.83-1.50],0.4494368238719431
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23303,2066,1.03 [0.99-1.07],0.1478709284804814
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22775,60,1.06 [0.85-1.32],0.6291257029980161
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Chronic sinusitis,22859,144,1.19 [1.03-1.37],0.0205331193423017
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23984,636,1.02 [0.95-1.09],0.6500048504298721
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Deviated nasal septum,22832,117,1.04 [0.89-1.22],0.5927853565733552
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22380,3731,1.04 [1.01-1.07],0.0084426424080774
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23049,334,1.03 [0.94-1.13],0.5483151387001372
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Early onset COPD,23802,454,1.00 [0.92-1.08],0.993704405316848
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Emphysema,21402,165,1.15 [1.00-1.31],0.0465067607406583
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22951,99,0.95 [0.81-1.13],0.5810225726220116
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23912,1057,1.02 [0.97-1.07],0.5014634261114699
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Interstitial lung disease,22973,121,0.99 [0.85-1.15],0.8706162396288772
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Later onset COPD,22787,182,1.07 [0.94-1.22],0.3074580801126363
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,24070,134,0.98 [0.85-1.13],0.7679753667166823
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Nasal polyp,22821,106,1.09 [0.92-1.29],0.3213293241221953
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23883,559,1.06 [0.99-1.14],0.106761104208331
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Other diseases of pleura,23921,1102,1.07 [1.02-1.13],0.0102463248771794
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23502,787,1.08 [1.02-1.15],0.0142942185674753
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Other pleural conditions,22851,32,1.05 [0.77-1.42],0.7656872762719042
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,24019,179,0.93 [0.82-1.05],0.245186034868336
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,24006,751,1.08 [1.02-1.15],0.0126245788273341
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Pleural effusion,23347,528,1.07 [1.00-1.16],0.0632441679357025
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Pleural plaque,22868,49,1.09 [0.85-1.39],0.4975745597050134
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23727,872,1.02 [0.96-1.08],0.5905971290258711
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,24052,116,1.01 [0.87-1.19],0.8648964906630451
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Pneumothorax,22876,57,1.20 [0.95-1.51],0.124808240333352
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Pollen allergy,24049,242,1.10 [0.98-1.23],0.091770511652493
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Pulmonary oedema,23876,36,0.80 [0.61-1.06],0.1176984880290257
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Respiratory insufficiency,17701,31,1.18 [0.86-1.61],0.3055124928304276
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23863,539,1.05 [0.98-1.13],0.1705790659243002
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22994,279,1.11 [1.00-1.23],0.0435563649908591
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Viral pneumonia,23020,165,1.00 [0.88-1.14],0.9796756699255954
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23840,141,0.99 [0.86-1.15],0.9347532903269288
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13844,86,0.89 [0.74-1.07],0.2041368177462142
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18402,54,0.95 [0.75-1.19],0.6483469221773618
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Acute appendicitis,23899,132,0.88 [0.76-1.02],0.0863481920308961
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Acute gastritis,19218,58,0.90 [0.72-1.12],0.3433911821940696
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Acute pancreatitis,22656,148,0.98 [0.86-1.13],0.812790529549191
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Acute peritonitis,23671,60,1.04 [0.83-1.30],0.7276729362916075
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23396,77,0.89 [0.73-1.07],0.2201943513460547
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Barrett oesophagus,19476,316,1.04 [0.94-1.14],0.4673694836481663
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22559,51,0.93 [0.73-1.17],0.5256145244571611
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23720,51,0.93 [0.73-1.18],0.536477539194183
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Cholecystitis,22665,157,0.96 [0.84-1.10],0.5887810964573045
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Cholelithiasis,23335,827,0.99 [0.93-1.05],0.7587984980012283
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Chronic gastritis,19380,220,1.04 [0.93-1.17],0.4943335431105999
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22546,38,0.82 [0.63-1.08],0.1568787510059608
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23945,76,0.76 [0.63-0.92],0.004527796632219
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Coeliac disease,22829,100,1.08 [0.91-1.29],0.3590496474064428
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Collagenous colitis,22701,49,1.13 [0.88-1.45],0.3262702681594038
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23908,180,0.93 [0.82-1.05],0.2441947161221709
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Constipation,23883,1019,1.04 [0.98-1.09],0.1725840789850227
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Crohn disease,22736,84,1.02 [0.85-1.23],0.8171146028129439
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23770,56,1.03 [0.82-1.29],0.8050305471202159
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22730,78,1.05 [0.86-1.27],0.6411241786247416
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Dental caries,23341,226,1.07 [0.95-1.20],0.2507565407002736
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22226,1574,1.02 [0.98-1.07],0.3501750461993487
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of appendix,23936,169,0.94 [0.82-1.07],0.3293429915195822
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of liver,23971,652,1.00 [0.93-1.06],0.8841649648517051
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22538,3378,1.00 [0.97-1.03],0.9685927818999872
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23649,534,1.06 [0.98-1.14],0.1345229472234673
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of peritoneum,24004,393,1.07 [0.98-1.16],0.1362754664422565
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23232,117,1.14 [0.97-1.34],0.1019599363732913
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of salivary glands,23093,61,1.14 [0.91-1.42],0.2601809587425571
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23830,1101,1.06 [1.01-1.12],0.0216082924501221
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of tongue,23095,106,1.03 [0.87-1.22],0.7257422608037849
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23625,1117,0.98 [0.94-1.04],0.5507141680215921
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20487,2139,1.03 [0.99-1.07],0.1429467400868038
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Duodenal ulcer,19287,127,0.99 [0.85-1.15],0.9152154851080152
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",24010,99,0.97 [0.82-1.15],0.7104459802220082
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23960,72,1.25 [1.02-1.54],0.0303501933744501
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23413,94,0.87 [0.73-1.03],0.0987103830159255
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18504,156,0.92 [0.80-1.05],0.2165824421754303
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Functional dyspepsia,19614,454,0.99 [0.92-1.07],0.8484387467153868
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Gastric ulcer,19414,254,0.92 [0.83-1.02],0.1192190557723534
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21131,1971,1.02 [0.98-1.06],0.2348243325455219
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19526,366,0.95 [0.87-1.04],0.2484164469332903
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19580,6972,1.01 [0.99-1.03],0.2537307553676828
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,GI-bleeding,23608,879,1.03 [0.98-1.09],0.2721947488833483
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23175,60,1.08 [0.86-1.35],0.5174845717550394
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,19144,1112,1.07 [1.01-1.12],0.0125083065997971
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23365,46,0.97 [0.76-1.25],0.8376557343579374
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Hernia,23031,2379,1.02 [0.98-1.05],0.390114491928327
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Impacted teeth,23970,67,1.32 [1.07-1.64],0.009879120626117
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Impaction of intestines,18380,32,1.30 [0.95-1.77],0.0955473137595366
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Inguinal hernia,21249,597,1.02 [0.95-1.09],0.6660757400987198
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",20723,71,0.98 [0.80-1.20],0.8281256546758193
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,18412,64,0.93 [0.75-1.14],0.4811687724672653
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22850,121,1.20 [1.03-1.41],0.0221356832292713
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18854,506,1.05 [0.97-1.13],0.209696747746235
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,24050,342,1.09 [1.00-1.20],0.0591451320272722
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23263,611,1.06 [0.99-1.14],0.0757581629552913
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23421,769,1.09 [1.02-1.16],0.0087116349340149
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19281,121,1.22 [1.04-1.43],0.0153062247220796
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Oesophagitis,19585,425,1.06 [0.97-1.15],0.18024628430292
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,24035,116,1.03 [0.88-1.21],0.6915609371227684
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20695,43,1.29 [0.99-1.68],0.0613438367596548
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19483,1135,1.01 [0.96-1.06],0.6892577685823764
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22680,172,0.95 [0.84-1.08],0.4565647938850915
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22649,141,0.90 [0.78-1.03],0.1255813685228334
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of intestine,19680,1332,1.01 [0.96-1.06],0.7318444938217967
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of intestines,22615,4267,1.01 [0.99-1.04],0.3040636894892683
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23093,169,1.05 [0.92-1.20],0.4361545898652536
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of liver,23844,525,1.00 [0.93-1.07],0.9344571913190348
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19640,480,1.01 [0.94-1.10],0.716412403430119
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22580,72,1.02 [0.84-1.25],0.8148891532960179
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23956,345,1.07 [0.98-1.17],0.1492717561885899
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19833,673,0.97 [0.91-1.03],0.3169514186895658
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23622,893,1.04 [0.98-1.10],0.2315466661188245
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23266,151,1.04 [0.90-1.19],0.6106648635897565
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19411,1063,1.04 [0.99-1.10],0.1374856527832661
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),20701,1541,0.97 [0.92-1.01],0.1104819324229502
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23391,72,0.82 [0.68-1.00],0.048515559507012
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23321,669,1.06 [0.99-1.13],0.0822627883851761
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18560,212,1.08 [0.96-1.21],0.2204077923022463
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23945,85,1.17 [0.97-1.42],0.0959379762499962
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18660,312,1.03 [0.94-1.13],0.5444266569256105
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22852,123,1.16 [0.99-1.35],0.0627348620038238
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Recurring oral aphthae,24065,53,0.98 [0.78-1.24],0.8945950116753862
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,23126,109,1.03 [0.87-1.21],0.7382958976458023
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Toxic colitis,22674,22,0.82 [0.57-1.17],0.2686509735517211
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19328,168,1.07 [0.94-1.22],0.3174311621255939
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Ulcerative colitis,22782,130,1.25 [1.08-1.46],0.0036454707682038
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22765,113,1.22 [1.03-1.43],0.0178108636628463
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Umbilical hernia,20889,237,0.96 [0.86-1.07],0.4375554283783051
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,18439,91,1.13 [0.95-1.36],0.1734373779806269
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Ventral hernia,20857,205,1.07 [0.95-1.20],0.2726044043815389
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Volvulus,18406,58,1.05 [0.84-1.31],0.679479337004276
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,24035,135,0.97 [0.84-1.12],0.6874332759677411
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23842,73,0.95 [0.78-1.16],0.5993555707729374
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22771,127,1.02 [0.88-1.18],0.8131502424734445
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23512,489,0.97 [0.90-1.04],0.3946793019640766
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23200,177,1.03 [0.90-1.16],0.7027633082395468
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22795,151,0.99 [0.87-1.14],0.936103495430146
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23844,202,1.10 [0.98-1.25],0.1060474400673068
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23985,343,1.07 [0.98-1.17],0.1500085822806505
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23682,40,1.16 [0.89-1.53],0.274830830417392
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22785,2249,1.01 [0.98-1.05],0.4410015569448122
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23672,375,0.93 [0.86-1.02],0.1256152676852278
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23561,264,0.96 [0.86-1.06],0.3924618038695954
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23721,698,0.98 [0.92-1.04],0.4677418887699593
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",24064,41,1.15 [0.88-1.51],0.3094870195640273
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,22697,53,0.92 [0.73-1.16],0.4796162473258368
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23334,37,1.11 [0.84-1.48],0.4569574573388879
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23838,196,1.11 [0.98-1.26],0.0928524177587031
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22909,265,1.11 [1.00-1.24],0.050119876209281
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,22678,34,1.09 [0.81-1.47],0.5567511525062021
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23999,64,1.03 [0.83-1.27],0.8094840609039419
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,23140,117,1.11 [0.95-1.30],0.1942941615895198
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23902,133,0.84 [0.73-0.97],0.0202115274700937
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23666,24,0.85 [0.60-1.20],0.3667571135612057
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,22690,46,1.01 [0.78-1.29],0.9608565998285786
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23622,978,1.03 [0.97-1.08],0.3494214005111378
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22937,293,1.15 [1.04-1.28],0.0060298689271026
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,22682,38,1.19 [0.90-1.58],0.2197790926796978
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,24003,234,0.94 [0.84-1.05],0.2997202660538882
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23697,55,0.91 [0.72-1.14],0.4054267559937144
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23960,191,0.92 [0.81-1.04],0.172310277086314
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,24049,149,0.96 [0.84-1.10],0.5620269317162179
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22750,106,1.10 [0.93-1.30],0.2578421923134259
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22811,167,1.06 [0.93-1.21],0.3730718791049014
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,24044,144,0.97 [0.84-1.11],0.6383864167688149
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22760,116,0.97 [0.83-1.13],0.6620277564845634
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,24043,108,1.01 [0.86-1.19],0.923150929242577
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,21091,115,1.07 [0.91-1.25],0.4235003825263385
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22441,4070,1.00 [0.97-1.02],0.7648675123946491
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21247,2876,0.99 [0.96-1.03],0.7224784002158706
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,21062,86,1.00 [0.84-1.21],0.9710554785999554
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21570,139,1.04 [0.90-1.20],0.6098569474046865
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21572,141,1.08 [0.93-1.24],0.3176206337877924
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23872,105,0.90 [0.76-1.06],0.1959322438369161
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",21474,43,0.81 [0.63-1.04],0.0931237427633652
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19041,670,0.98 [0.91-1.04],0.4762082663335762
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",24021,114,0.94 [0.81-1.11],0.4749701886175435
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21680,249,1.03 [0.93-1.15],0.5386781150273052
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,21020,5462,1.01 [0.99-1.03],0.5000155931909804
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22847,97,0.92 [0.78-1.10],0.3657874160553396
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,21078,102,0.87 [0.74-1.03],0.1058843391303911
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21522,546,1.05 [0.98-1.13],0.1694099510127423
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23278,1847,1.02 [0.98-1.06],0.36242300406689
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,21179,203,1.16 [1.02-1.31],0.0188772929992001
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,21236,260,1.09 [0.98-1.21],0.1087750210862825
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,21108,132,1.16 [1.00-1.35],0.0513245059546983
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23598,32,0.98 [0.73-1.32],0.8907217267938724
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19507,1136,1.02 [0.97-1.07],0.5493259380241524
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18714,343,1.01 [0.92-1.11],0.7694686184732558
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",24027,333,1.02 [0.93-1.12],0.7166351806122917
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18439,68,0.96 [0.78-1.18],0.7131679824419606
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18679,308,0.89 [0.81-0.98],0.0170859196950997
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21264,288,1.01 [0.91-1.11],0.8684409847534158
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19038,667,1.00 [0.93-1.07],0.9289326011158996
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,21455,24,0.88 [0.62-1.24],0.4582654362589267
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21928,497,1.03 [0.95-1.11],0.5005863177902109
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21684,253,1.02 [0.91-1.13],0.7713428339966484
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18990,619,0.99 [0.92-1.06],0.7786930443436918
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,21043,67,1.20 [0.97-1.48],0.0942255620887566
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",21031,55,0.92 [0.73-1.15],0.4712392990649022
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22803,53,1.04 [0.82-1.31],0.76053601154793
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23783,1033,0.97 [0.92-1.02],0.2335416282033217
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23331,581,0.97 [0.91-1.04],0.45405562864828
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23969,307,1.05 [0.95-1.15],0.3700883024834732
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19925,1554,0.99 [0.95-1.03],0.6040539823072139
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18439,68,1.00 [0.81-1.22],0.9689223323957056
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,21045,69,1.09 [0.88-1.34],0.4220805117769756
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18396,25,0.79 [0.57-1.11],0.1783948932134083
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18474,103,0.98 [0.83-1.16],0.8245764064341026
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22959,209,0.97 [0.86-1.09],0.6243361980554518
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22974,224,0.98 [0.87-1.10],0.7039877334788583
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,24039,74,0.95 [0.78-1.16],0.612634427025986
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22820,1389,1.03 [0.99-1.08],0.1789894997812466
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,21083,107,0.86 [0.73-1.01],0.0615380397594538
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18483,112,0.85 [0.73-1.00],0.0451138243814657
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21989,558,1.00 [0.93-1.07],0.893567217999512
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20174,1803,0.99 [0.95-1.03],0.6899091167776461
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23617,51,1.03 [0.81-1.31],0.8001722407002857
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,24051,68,0.98 [0.80-1.20],0.8456645304350671
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,21046,70,1.12 [0.91-1.38],0.2868656506061673
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21949,973,1.02 [0.97-1.08],0.491697461109655
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,21036,60,0.92 [0.74-1.15],0.4732972268594069
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19368,997,1.03 [0.98-1.09],0.2666558447333353
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22845,95,1.00 [0.84-1.19],0.9749107471431446
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,21035,59,1.13 [0.90-1.42],0.2851351483063596
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,21531,100,1.00 [0.84-1.18],0.9551105628859768
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21324,348,0.96 [0.88-1.05],0.3994797896486936
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23755,189,1.02 [0.90-1.16],0.7234071823866528
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21854,423,1.04 [0.95-1.13],0.4028401064832929
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23978,292,1.06 [0.96-1.17],0.2562466908539594
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,24058,34,0.95 [0.71-1.27],0.7352726130452798
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,21162,186,1.01 [0.89-1.15],0.8504421181588147
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19291,545,1.05 [0.98-1.13],0.16210669064485
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21416,440,0.97 [0.90-1.05],0.4567580495727751
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],21127,151,1.15 [1.00-1.33],0.0464405156873219
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18405,34,0.83 [0.63-1.11],0.2172281262147138
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19936,1565,1.02 [0.98-1.07],0.3012481791949257
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18769,398,0.94 [0.86-1.03],0.1646367022516099
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23644,78,1.07 [0.88-1.30],0.4755667697276152
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",24009,44,0.93 [0.72-1.20],0.5669018779543196
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",22676,26,1.10 [0.79-1.54],0.5588877214687177
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18441,70,0.98 [0.80-1.20],0.8227757140922882
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,21511,80,1.10 [0.91-1.34],0.3171825182705439
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18681,310,1.04 [0.95-1.15],0.3909514659406726
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21216,240,0.96 [0.86-1.08],0.5128270851712808
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21623,192,1.08 [0.95-1.22],0.2510179134190785
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,21522,91,1.00 [0.83-1.19],0.9598213218276914
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,20341,44,1.15 [0.88-1.49],0.3006379479287684
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",24061,37,0.92 [0.69-1.21],0.5377270314912598
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21502,526,1.00 [0.93-1.08],0.9384142802554069
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],23643,77,0.93 [0.77-1.13],0.454680165980362
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,23125,2149,1.02 [0.99-1.06],0.1999882602473416
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",21076,100,0.99 [0.84-1.18],0.9231321918514812
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21749,318,1.06 [0.96-1.17],0.2475314852581719
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22828,164,1.05 [0.91-1.19],0.5155092023401961
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,21563,132,1.06 [0.91-1.23],0.4442816416532947
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22377,946,1.00 [0.95-1.06],0.8987595545173733
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,22051,620,0.96 [0.90-1.03],0.2998157432194153
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],21015,39,1.10 [0.83-1.45],0.5230583240553972
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23709,143,1.01 [0.87-1.16],0.9100143825677272
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,21115,139,1.07 [0.93-1.24],0.3375740344351083
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,21029,53,0.89 [0.71-1.12],0.3241212539180707
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18404,33,1.00 [0.74-1.35],0.9909454395689046
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Acute renal failure,23615,749,1.03 [0.97-1.10],0.341248155534592
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9771,63,1.03 [0.83-1.28],0.772164234737516
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,13003,72,0.85 [0.69-1.03],0.0937740698729529
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23817,272,0.96 [0.87-1.07],0.4761189095783209
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23599,54,0.85 [0.68-1.07],0.1684876308017094
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23428,562,0.99 [0.92-1.06],0.7650928889832875
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23915,19,0.58 [0.41-0.84],0.0034141140608232
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23921,160,0.99 [0.86-1.13],0.8683310419644841
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Cystitis,22124,136,0.90 [0.78-1.04],0.1594249843558665
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Dialysis,22908,42,1.18 [0.90-1.53],0.2304361072648993
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10406,987,1.02 [0.97-1.08],0.4428748001867243
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Disorders of breast,13105,174,0.92 [0.81-1.05],0.2061281762014347
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Endometriosis,9822,114,0.98 [0.84-1.16],0.8412404267402632
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",10039,331,0.90 [0.82-0.98],0.0220764597917154
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,10081,373,1.02 [0.93-1.11],0.716477095820726
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20282,3695,1.00 [0.98-1.03],0.8188313917530398
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23954,58,1.02 [0.82-1.27],0.8562339119542346
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Hydrocele,9488,69,1.18 [0.96-1.46],0.1107021845000897
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,22790,195,1.01 [0.90-1.14],0.8312492156219846
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,10075,656,1.03 [0.97-1.10],0.3503713820888131
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12983,207,0.93 [0.83-1.05],0.2244827770173306
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9512,93,0.90 [0.75-1.07],0.2213956943076359
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Irregular menses,13003,106,0.76 [0.64-0.89],0.0007017239313758
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Menorrhagia,9966,258,0.99 [0.89-1.11],0.8950760324329057
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,22042,54,1.04 [0.82-1.31],0.745327179900674
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10931,1223,0.99 [0.94-1.04],0.7370906184766108
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,9466,47,0.97 [0.76-1.25],0.832869851971676
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9795,87,1.16 [0.96-1.40],0.1181753017058472
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",24065,35,1.09 [0.81-1.46],0.5709789857381546
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",24070,42,0.93 [0.72-1.21],0.5868269842122069
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23309,1321,1.02 [0.97-1.07],0.3710925448011691
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22399,411,1.00 [0.92-1.09],0.9486085613307556
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,12986,55,0.99 [0.79-1.25],0.937580238382618
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,24028,267,1.01 [0.91-1.12],0.8646292158840007
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9556,137,0.96 [0.83-1.11],0.5447620844117873
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9523,104,0.93 [0.79-1.10],0.3931811931869962
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,9481,62,1.04 [0.84-1.29],0.7193034798821065
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,24041,50,1.07 [0.84-1.36],0.6033443768538427
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22963,975,1.03 [0.97-1.09],0.3147158924203367
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,12883,107,1.03 [0.87-1.21],0.7364242242426262
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9777,69,1.12 [0.91-1.38],0.2689332706762071
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9912,204,1.05 [0.93-1.19],0.3938213991430491
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9762,54,1.29 [1.02-1.64],0.036645000575967
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9803,95,1.08 [0.90-1.28],0.4070430442819344
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22820,225,1.02 [0.91-1.14],0.7778226999974442
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23853,92,1.00 [0.84-1.20],0.9592292021606816
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9858,150,1.03 [0.89-1.18],0.689120472660302
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9776,68,1.03 [0.83-1.27],0.801270191763211
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10074,366,1.00 [0.91-1.09],0.9358350957623832
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9765,57,0.89 [0.71-1.11],0.2844469823723662
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,10031,323,1.04 [0.95-1.14],0.4081644992490899
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23936,40,1.04 [0.80-1.37],0.7641082020523116
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9514,95,1.11 [0.93-1.32],0.2473537267758197
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23912,1317,1.01 [0.97-1.06],0.5578673796289777
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",22719,124,1.00 [0.86-1.16],0.9788974527253635
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22925,59,0.90 [0.72-1.11],0.3235496660643455
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23606,61,0.98 [0.79-1.22],0.8575453743474611
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Urethral stricture,22133,145,1.10 [0.95-1.27],0.1978474550638463
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23875,330,0.95 [0.86-1.04],0.2618387239610408
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9793,85,1.11 [0.92-1.34],0.2813466778367031
